UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061872
Receipt number R000070796
Scientific Title An Evaluation of the Initial Efficacy of a One-Handed Game Controller: A Randomized Crossover Trial
Date of disclosure of the study information 2026/06/15
Last modified on 2026/06/11 15:44:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An Evaluation of the Initial Efficacy of a One-Handed Game Controller: A Randomized Crossover Trial

Acronym

An Evaluation of the Initial Efficacy of a One-Handed Game Controller: A Randomized Crossover Trial

Scientific Title

An Evaluation of the Initial Efficacy of a One-Handed Game Controller: A Randomized Crossover Trial

Scientific Title:Acronym

An Evaluation of the Initial Efficacy of a One-Handed Game Controller: A Randomized Crossover Trial

Region

Japan


Condition

Condition

Cerebrovascular disease

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim is to conduct an exploratory evaluation of the device's feasibility and initial efficacy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Time taken to complete the self-made game evaluation assignment

Key secondary outcomes

Japanese Version of the System Usability Scale
Japanese Version of the Game Engagement Questionnaire
User Experience Questionnaire (Likert scale)
The User Experience Questionnaire consists of sections on enjoyment, fatigue, intention to continue using the product, purchase intention (whether the respondent wishes to purchase the product and their acceptable price), device malfunctions, and open-ended comments.


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Conduct an evaluation of a custom-made game using the one-handed game controller developed in this study

Interventions/Control_2

Conducting a self-designed game evaluation task using an existing one-handed game grip

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Patients who have experienced a first stroke and exhibit symptoms on only one side (regardless of symptom severity)
2) Patients capable of operating this device or an existing single-hand game controller with either their left or right upper limb
3) Patients who can maintain a seated position independently, or who can safely maintain a seated position in their usual chair or wheelchair

Key exclusion criteria

1)Individuals with impaired cognitive function (MMSE score of 23 or lower)
2)Individuals who have difficulty understanding or performing game tasks or answering questionnaires due to higher-level cognitive impairments such as severe visual or hearing impairments, aphasia, or attention disorders
3)Individuals deemed unable to participate safely due to pain, fatigue, dizziness, blood pressure fluctuations, or poor general health
4)Individuals for whom game operation is deemed inappropriate due to upper limb immobilization or weight-bearing restrictions, postoperative contraindications, or activity restrictions prescribed by a physician
5)Individuals from whom informed consent for the study cannot be obtained

Target sample size

24


Research contact person

Name of lead principal investigator

1st name Moe
Middle name
Last name Fujita

Organization

Sonoda-kai Neuro-Rehabilitation Hospital

Division name

Department of Rehabilitation

Zip code

120-0012

Address

1-10-10 Aoi, Adachi Ward, Tokyo

TEL

03-5845-0126

Email

araimmm.0201@gmail.com


Public contact

Name of contact person

1st name Moe
Middle name
Last name Fujita

Organization

Sonoda-kai Neuro-Rehabilitation Hospital

Division name

Department of Rehabilitation

Zip code

123-0012

Address

1-10-10 Aoi, Adachi Ward, Tokyo

TEL

03-5845-0126

Homepage URL


Email

araimmm.0201@gmail.com


Sponsor or person

Institute

Sonoda-kai Neuro-Rehabilitation Hospital

Institute

Department

Personal name

Moe Fujita


Funding Source

Organization

Sonoda-kai Neuro-Rehabilitation Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sonodakai Medical Corporation

Address

3-4-10 Hokima, Adachi Ward, Tokyo

Tel

03-5851-7551

Email

irb@sonodakai.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

苑田会ニューロリハビリテーション病院(東京都)


Other administrative information

Date of disclosure of the study information

2026 Year 06 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 06 Month 06 Day

Date of IRB

2026 Year 06 Month 06 Day

Anticipated trial start date

2026 Year 06 Month 10 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 06 Month 11 Day

Last modified on

2026 Year 06 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070796